Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Nuclear factor kappa-B (NF-kappaB)-regulated inflammatory genes, such as TNF-alpha (tumor necrosis factor-alpha), play key roles in the pathogenesis of inflammatory diseases, including diabetes and the metabolic syndrome. However, the nuclear chromatin mechanisms are unclear. We report here that the chromatin histone H3-lysine 4 methyltransferase, SET7/9, is a novel coactivator of NF-kappaB. Gene silencing of SET7/9 with small interfering RNAs in monocytes significantly inhibited TNF-alpha-induced inflammatory genes and histone H3-lysine 4 methylation on these promoters, as well as monocyte adhesion to endothelial or smooth muscle cells. Chromatin immunoprecipitation revealed that SET7/9 small interfering RNA could reduce TNF-alpha-induced recruitment of NF-kappaB p65 to inflammatory gene promoters. Inflammatory gene induction by ligands of the receptor for advanced glycation end products was also attenuated in SET7/9 knockdown monocytes. In addition, we also observed increased inflammatory gene expression and SET7/9 recruitment in macrophages from diabetic mice. Microarray profiling revealed that, in TNF-alpha-stimulated monocytes, the induction of 25% NF-kappaB downstream genes, including the histone H3-lysine 27 demethylase JMJD3, was attenuated by SET7/9 depletion. These results demonstrate a novel role for SET7/9 in inflammation and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the diabetic mouse model, there is enhanced recruitment of histone methyltransferase SET7 to the MCP-1 promoter region, which results in increased histone H3-lysine 4 methylation and higher MCP-1 expression in macrophages treated with TNF-α [181].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [181]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398
Self-citationThe complex language of chromatin regulation during transcription
Berger, S. L. (2007) · Nature · doi:10.1038/nature05915 · Cited by 2,768
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057
Cited by
Items 301–357 of 357
Histone methylation of kidney disease: fact or fantasy?
Hu, L., Jin, H., Xu, L., Hu, Q., & Zhang, X. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2538801 · Cited by 2
Abuelrub, A., Erol, İ., & Durdağı, S. (2025) · ACS Omega · doi:10.1021/acsomega.5c02521 · Cited by 2
Epigenetics of pain highways (Review)
Aneja, K. K. (2025) · International Journal of Epigenetics · doi:10.3892/ije.2025.30 · Cited by 2
Chen, J., Chen, Y., Chen, W., Yingjie, T., Wang, T., Xie, Y., Wang, B., & Luo, J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112352 · Cited by 2
The Role of Inflammation in Type 2 Diabetes-Driven Atherosclerosis
Enns, J. E., Taylor, C. G., & Zahradka, P. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9317-4_13 · Cited by 3
Innate immunity in diabetic nephropathy: Pathogenic mechanisms and therapeutic targets
Chen, L., Lu, S., Wu, Z., Zhang, E., Cai, Q., & Zhang, X. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.76 · Cited by 2
The Potential of Epigenetic Compounds in Treating Diabetes
Gray, S. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00017-2 · Cited by 7
Iba, Y., Watanabe, K., Ozaki, K., Aozasa, O., Ishizawa, K., Matsuura, T., Oyama, H., & Masukawa, T. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.01.007 · Cited by 2
Epigenetics of Diabetes in Humans
Nano, J., Portilla-Fernández, E., Troup, J., Ghanbari, M., Franco, O. H., & Muka, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00016-9 · Cited by 3
Epigenetics of Diabetic Microvascular Disease
Pirola, L. (2020) · Wiley eBooks · doi:10.1002/9781119309642.ch4 · Cited by 2
Epigenetics of autoimmune diseases
Farhadi, E., & Mahmoudi, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814259-2.00009-1 · Cited by 1
Role of Epigenetics in the Complications Associated with Diabetes and Related Metabolic Disorders
Villeneuve, L. M., & Natarajan, R. D. (2011) · CRC Press eBooks · doi:10.1201/b11294-5 · Cited by 1
Self-citationEpigenetics and the Regulation of Nitric Oxide
Handy, D. E., & Loscalzo, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-46189-2_4 · Cited by 1
DANCR maintained colon epithelial homeostasis by regulating the TNFα/NF-κB pathway
Peng, L., Shi, Y., Deng, J., Chen, K. J., Peng, X., & Zhong, X. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150176 · Cited by 1
Epigenetic Diabetic Vascular Complications
Amiri, A. A., & Amiri, A. A. (2016) · Journal of Pediatrics Review · doi:10.17795/jpr-3375 · Cited by 1
Narne, P. (2019) · Springer eBooks · doi:10.1007/978-981-13-8946-7_18 · Cited by 1
Epigenetics and Type 2 Diabetes
Ling, C., Rönn, T., & Nitert, M. D. (2011) · Springer eBooks · doi:10.1007/978-1-84882-644-1_9 · Cited by 1
Chromatin at the Intersection of Disease and Therapy
Quénet, D., Walkiewicz, M. P., & Dalal, Y. (2012) · Wiley eBooks · doi:10.1002/9781118349045.ch4 · Cited by 1
Electronic patient record for N.N. Burdenko Neurosurgical Institute: on the verge of implementation.
Shifrin, M. A., & Kalinina, E. E. (1999) · PubMed · Cited by 1
Endothelial–Mesenchymal Transition Switch and Diabetic Kidney Disease
Doke, T., & Bjornstad, P. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000364 · Cited by 1
Search for molecular and metabolic mechanisms contributing to impaired β-cell function
Malmgren, S. (2012) · Lund University Publications (Lund University)
The Role of DNA Methylation in Type 1 and 2 Diabetes as Related to Endothelial Cell Dysfunction
Sarras, M. P. (2015) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2015.01.00005
“While extensive epigenetic research has been conducted regarding histone modifications [41-50] and microRNA mechanisms [5,51-56] much less is known about the role of HGinduced persistent DNA methylation changes that occur in both type 1 and 2 DM.”
BackgroundLas terapias epigenéticas, más allá de los biológicos en el tratamiento de la artritis reumatoide
Sánchez‐Pernaute, O. (2010) · Reumatología Clínica · doi:10.1016/j.reuma.2009.10.013
Mechanisms of transcriptional regulation in the maintenance of β cell function
Maganti, A. V. (2015) · IUScholarWorks (Indiana University) · doi:10.7912/c2b88b
Diabetic nephropathy—emerging epigenetic
Natarajan, R. D. (2014)
Self-citationEpigenomics of Diabetes Mellitus
Dimova, I. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814513-5.00012-x
The contribution of methyltransferases : demethylases to renal fibrosis
Nawafa, L. S. O. (2018)
Dietary and Metabolic Compounds Affecting Covalent Histone Modifications
Davison, G. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00024-4
[Research Progress of Role and Mechanism of SETD7 in Tumor Occurrence and Progression].
Cao, L., Wang, M., & Xu, K. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.106.02 · Cited by 1
HİPERGLİSEMİNİN EPİGENETİK MEKANİZMALAR İLE İLİŞKİSİ
Selçuk, E., ÖZKAHRAMAN, D., Foenna, Y. G., & Calapoğlu, N. Ş. (2023) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.1273169
Zhu, S., Tao, M., Li, Y., Wang, X., Zhao, Z., Liu, Y., Li, Q., Li, Q., Lu, Y., Si, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23730796
Self-citationEpigenetic Regulation Mediating Immunopathology in Parkinson’s Disease
Khan, S. S., & Khatri, D. K. (2025) · RNA technologies · doi:10.1007/978-3-031-91072-2_13 · Cited by 1
Functional implications of epigenetics in cardiovascular disease
Nguyen, H. C., & Singh, K. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00045-1
Atherosclerosis in the context of hemostasis and neovascularization – Current state of knowledge
Jakobsche-Policht, U., Bronowicka-Szydełko, A., Adamiec, R., Bednarska-Chabowska, D., Królewicz, E., Lewandowski, Ł., Gostomska‐Pampuch, K., Derkacz, A., Budrewicz, K., Grzebyk, E., et al. (2025) · Advances in Medical Sciences · doi:10.1016/j.advms.2025.09.002
Wasiak, S., Dzobo, K. E., Rakai, B. D., Kaiser, Y., Versloot, M., Bahjat, M., Stotz, S. C., Fu, L., Sweeney, M., Johansson, J. O., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13219203
Zhu, S., Tao, M., Li, Y., Wang, X., Zhao, Z., Liu, Y., Li, Q., Li, Q., Lu, Y., Si, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23730790
Self-citationWasiak, S., Dzobo, K. E., Rakai, B. D., Kaiser, Y., Versloot, M., Bahjat, M., Stotz, S. C., Fu, L., Sweeney, M., Johansson, J. O., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13219206
Zhu, S., Tao, M., Li, Y., Wang, X., Zhao, Z., Liu, Y., Li, Q., Li, Q., Lu, Y., Si, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23730778
Self-citationZhu, S., Tao, M., Li, Y., Wang, X., Zhao, Z., Liu, Y., Li, Q., Li, Q., Lu, Y., Si, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23730787
Self-citationZhu, S., Tao, M., Li, Y., Wang, X., Zhao, Z., Liu, Y., Li, Q., Li, Q., Lu, Y., Si, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23730781
Self-citationZhu, S., Tao, M., Li, Y., Wang, X., Zhao, Z., Liu, Y., Li, Q., Li, Q., Lu, Y., Si, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23730793
Self-citationZhu, S., Tao, M., Li, Y., Wang, X., Zhao, Z., Liu, Y., Li, Q., Li, Q., Lu, Y., Si, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23730784
Self-citationEpigenetic marks and promising epigenetic therapies
Kankaya, S., & Dinçer, Y. (2026) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen8132
Epigenetic modulators in cancer therapy: Treatment and beyond
Sharma, K., Chib, S., Chauhan, K., Amanat, M., Tariq, M., Srivastava, S., Sahu, R., Sharma, N., & Behl, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31592-3.00018-2
Mechanisms controlling transcription in hypoxia; an unexpected role of NF-κB
Shakir, D., Batie, M., & Rocha, S. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.03.030
The Role of Histone Methylation in Heart Failure: Epigenetic Mechanisms and Therapeutic Perspectives
Zhou, Y., Dong, Z., Gao, Y., Xiao, K., Huang, Q., Cao, Q., Wang, X., Duan, Y., Guo, Z., & Wei, J. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s578812
The role of PRMT5-mediated methylation of steroid receptor in breast Cancer
Pham, T. H. (2022) · theses.fr (ABES) · doi:10.70675/f6e3d282z871dz4ffaz87bazb04f22d60d50 · Cited by 1
Histone Methylation: A Pivotal Epigenetic Driver of the Malignant Transformation of MASLD-HCC
Zhang, Y., Chen, T., Chang, Z., Qi, X., Yan, R., Zhang, H., Guan, X., Yan, S., Li, J., & Jiao, J. (2026) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s598429 · Cited by 1
Knight, T. W. C., Saaoud, F., Asangwe, N., Shao, Y., Khan, I., Kubo, H., Khan, M., Wang, H., Kishore, R., Yang, X., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104383
“3B), alongside factors involved in RNA processing and protein folding, collectively reinforcing a stable, low-inflammatory, oxidative metabolic state [36 – 41].”
BindingDB Entry 50040549: Oncoepigenomics: making histone lysine methylation count.
BindingDB (2013) · UC San Diego · doi:10.7270/q2tq62nx
Dietary and Metabolic Compounds Affecting Chromatin Dynamics/Remodeling
Milagro, F. I., Campión, J., & Martínez, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375709-8.00018-6
Environment, Epigenetic Changes, and Cardiovascular Damage
Paneni, F., & Cosentino, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17762-5_4
Metadata
- Authors
- Li, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R.
- Affiliations
- City Of Hope National Medical Center (US)
- University of California San Diego (US)
- Corresponding author
- Natarajan, Rama
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 283
- Issue
- 39
- Pages
- 26771-26781
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2546554
- OpenAlex
- W2163002796
- Cited by
- 353
- References
- 43
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 12 · 2023: 21 · 2022: 21 · 2021: 23 · 2020: 20 · 2019: 15 · 2018: 24 · 2017: 15 · 2016: 20 · 2015: 22 · 2014: 23 · 2013: 23 · 2012: 29
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4393 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01 HL87864, R01HL087864)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065073)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- SET7/9, histone H3 lysine 4 methylation, NF-κB, TNF-α, inflammatory gene regulation, monocytes, macrophages, diabetes mellitus, metabolic syndrome, receptor for advanced glycation end products, JMJD3, histone demethylation, monocyte adhesion, endothelial cells, smooth muscle cells
- MeSH terms
- Histone Methyltransferases, Animals, Cell Line, Diabetes Mellitus, Experimental, Histones, Humans, Inflammation, Monocytes, Oxidoreductases, N-Demethylating, Promoter Regions, Genetic, Histone-Lysine N-Methyltransferase, Protein Methyltransferases, Tumor Necrosis Factor-alpha, Inflammation Mediators, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Metabolic Syndrome, RNA, Small Interfering, Mice, Transcription Factor RelA, Jumonji Domain-Containing Histone Demethylases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.